Article

Christine Solberg Strahl, PharmD, Discusses the Management of New Drugs on the Medical Benefit

Christine Solberg Strahl, PharmD, Specialty Pharmacy Program Manager, HealthPartners, says that by managing specialty drugs before utilization patterns are established there is less member and provider dissatisfaction.

Christine Solberg Strahl, PharmD, Specialty Pharmacy Program Manager, HealthPartners, says that by managing specialty drugs before utilization patterns are established there is less member and provider dissatisfaction. Using medical injectables as an example, Dr Strahl says that there are coding and pricing issues associated when managing new specialty drugs that are administered on the specialty benefit.

Related Videos
Sarah Anderson, oncology strategy lead director, Novotech
Gladys Antelo-Allen
Jonathan Eisengart, MD
Chelsee Jensen, PharmD, BCPS.
Jonathan Eisengart, MD
Sarah Anderson, oncology strategy lead director, Novotech
Jonathan Eisengart
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo